SHIKARI® Q-DUR

Enzyme immunoassay for the quantitative determination of free Durvalumab (Imfinzi®) in serum and plasma.

Enzyme immunoassay for the quantitative determination of free Durvalumab (Imfinzi®) in serum and plasma. The Matriks Biotek Shikari Q-DUR ELISA has been especially developed for the quantitative analysis of free Durvalumab in serum and plasma samples.



Click the diagram to see bigger

about-me




Required Volume (μl) 10
Total Time (min) 70
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) 10
Spike Recovery (%) Between 85-115
Shelf Life (year) 1

SHIKARI® S-ATDUR

Enzyme immunoassay for the qualitative determination of antibodies to Durvalumab in serum and plasma.

The Matriks Biotek® Antibody to durvalumab (Imfinzi®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to durvalumab (Imfinzi®) in serum and plasma. It is for professional use only.



Required Volume (μl) 10
Total Time (min) 140
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) + / -
Spike Recovery (%) -
Shelf Life (year) 1

MATRIKS BIOTECHNOLOGY CO., LTD

Gazi Üniversitesi Gölbaşı Yerleşkesi Teknoplaza Binası,
(B Blok Zemin Kat BZ17),
06830,
Gölbaşı/ANKARA/TURKIYE

Contact Details

Telephone: +90 (312) 485 42 94
Intl.calls&Whatsapp: +90 (546) 485 42 94
Email: info@matriksbiotek.com
Email: order@matriksbiotek.com
Fax: +90 (312) 485 11 87